Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy.

Frick AE, Nackaerts K, Moons J, Lievens Y, Verbeken E, Lambrecht M, Coolen J, Dooms C, Vansteenkiste J, De Leyn P, Nafteux P.

Eur J Cardiothorac Surg. 2018 Dec 6. doi: 10.1093/ejcts/ezy385. [Epub ahead of print]

PMID:
30535191
2.

RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissue.

Reynders K, Wauters E, Moisse M, Decaluwé H, De Leyn P, Peeters S, Lambrecht M, Nackaerts K, Dooms C, Janssens W, Vansteenkiste J, Lambrechts D, De Ruysscher D.

Radiat Oncol. 2018 Jul 17;13(1):131. doi: 10.1186/s13014-018-1075-1.

3.

Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus.

Lambrecht M, Eekers DBP, Alapetite C, Burnet NG, Calugaru V, Coremans IEM, Fossati P, Høyer M, Langendijk JA, Romero AM, Paulsen F, Perpar A, Renard L, de Ruysscher D, Timmermann B, Vitek P, Weber DC, van der Weide HL, Whitfield GA, Wiggenraad R, Roelofs E, Nyström PW, Troost EGC; work package 1 of the taskforce “European Particle Therapy Network” of ESTRO.

Radiother Oncol. 2018 Jul;128(1):26-36. doi: 10.1016/j.radonc.2018.05.001. Epub 2018 May 17. Review.

PMID:
29779919
4.

The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology.

Eekers DB, In 't Ven L, Roelofs E, Postma A, Alapetite C, Burnet NG, Calugaru V, Compter I, Coremans IEM, Høyer M, Lambrecht M, Nyström PW, Romero AM, Paulsen F, Perpar A, de Ruysscher D, Renard L, Timmermann B, Vitek P, Weber DC, van der Weide HL, Whitfield GA, Wiggenraad R, Troost EGC; “European Particle Therapy Network” of ESTRO.

Radiother Oncol. 2018 Jul;128(1):37-43. doi: 10.1016/j.radonc.2017.12.013. Epub 2018 Mar 13. Review.

5.

Is central lung tumour location really predictive for occult mediastinal nodal disease in (suspected) non-small-cell lung cancer staged cN0 on 18F-fluorodeoxyglucose positron emission tomography-computed tomography?

Decaluwé H, Moons J, Fieuws S, De Wever W, Deroose C, Stanzi A, Depypere L, Nackaerts K, Coolen J, Lambrecht M, Verbeken E, De Ruysscher D, Vansteenkiste J, Van Raemdonck D, De Leyn P, Dooms C; Leuven Lung Cancer Group.

Eur J Cardiothorac Surg. 2018 Jul 1;54(1):134-140. doi: 10.1093/ejcts/ezy018.

PMID:
29447330
6.

Standard of care in high-dose radiotherapy for localized non-small cell lung cancer.

De Ruysscher D, Lambrecht M, van Baardwijk A, Peeters S, Reymen B, Verhoeven K, Wanders R, Öllers M, van Elmpt W, van Loon J.

Acta Oncol. 2017 Nov;56(11):1610-1613. doi: 10.1080/0284186X.2017.1349337. Epub 2017 Aug 25. No abstract available.

PMID:
28840754
7.

Preoperative risk factors for prolonged postoperative ileus after colorectal resection.

Wolthuis AM, Bislenghi G, Lambrecht M, Fieuws S, de Buck van Overstraeten A, Boeckxstaens G, D'Hoore A.

Int J Colorectal Dis. 2017 Jun;32(6):883-890. doi: 10.1007/s00384-017-2824-6. Epub 2017 Apr 25.

PMID:
28444506
8.

Radiotherapy in combination with immune checkpoint inhibitors.

De Ruysscher D, Reynders K, Van Limbergen E, Lambrecht M.

Curr Opin Oncol. 2017 Mar;29(2):105-111. doi: 10.1097/CCO.0000000000000352. Review.

PMID:
28085679
9.

Do refined consensus guidelines improve the uniformity of clinical target volume delineation for rectal cancer? Results of a national review project.

Joye I, Macq G, Vaes E, Roels S, Lambrecht M, Pelgrims A, Bussels B, Vancleef A, Stellamans K, Scalliet P, Weytjens R, Christian N, Boulanger AS, Donnay L, Van Brussel S, Moretti L, Van den Bergh L, Van Eycken E, Debucquoy A, Haustermans K.

Radiother Oncol. 2016 Aug;120(2):202-6. doi: 10.1016/j.radonc.2016.06.005. Epub 2016 Jun 30.

PMID:
27373910
10.

Clinical and dosimetric evaluation of RapidArc versus standard sliding window IMRT in the treatment of head and neck cancer.

Smet S, Lambrecht M, Vanstraelen B, Nuyts S.

Strahlenther Onkol. 2015 Jan;191(1):43-50. doi: 10.1007/s00066-014-0742-x. Epub 2014 Aug 29.

PMID:
25168752
11.

Advances in the management of squamous cell carcinoma of the head and neck.

Machiels JP, Lambrecht M, Hanin FX, Duprez T, Gregoire V, Schmitz S, Hamoir M.

F1000Prime Rep. 2014 Jun 2;6:44. doi: 10.12703/P6-44. eCollection 2014. Review.

12.

Does a central review platform improve the quality of radiotherapy for rectal cancer? Results of a national quality assurance project.

Joye I, Lambrecht M, Jegou D, Hortobágyi E, Scalliet P, Haustermans K.

Radiother Oncol. 2014 Jun;111(3):400-5. doi: 10.1016/j.radonc.2014.03.003. Epub 2014 Apr 17.

PMID:
24746578
13.

Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma.

Lambrecht M, Van Calster B, Vandecaveye V, De Keyzer F, Roebben I, Hermans R, Nuyts S.

Radiother Oncol. 2014 Mar;110(3):429-34. doi: 10.1016/j.radonc.2014.01.004. Epub 2014 Mar 11.

PMID:
24630535
14.

Noncutaneous head and neck cancer in solid organ transplant patients: single center experience.

Nelissen C, Lambrecht M, Nevens F, Van Raemdonck D, Vanhaecke J, Kuypers D, Pirenne J, Nuyts S.

Oral Oncol. 2014 Apr;50(4):263-8. doi: 10.1016/j.oraloncology.2013.12.016. Epub 2014 Jan 6.

PMID:
24394561
15.

Redefining the target early during treatment. Can we visualize regional differences within the target volume using sequential diffusion weighted MRI?

Lambrecht M, Van Herck H, De Keyzer F, Vandecaveye V, Slagmolen P, Suetens P, Hermans R, Nuyts S.

Radiother Oncol. 2014 Feb;110(2):329-34. doi: 10.1016/j.radonc.2013.09.023. Epub 2013 Nov 11.

PMID:
24231234
16.

Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicity.

Nuyts S, Lambrecht M, Duprez F, Daisne JF, Van Gestel D, Van den Weyngaert D, Platteaux N, Geussens Y, Voordeckers M, Madani I, De Neve W.

Radiother Oncol. 2013 Nov;109(2):323-9. doi: 10.1016/j.radonc.2013.06.044. Epub 2013 Aug 13.

PMID:
23953410
18.

The ESTRO Breur Lecture 2010: toward a tailored patient approach in rectal cancer.

Haustermans K, Debucquoy A, Lambrecht M.

Radiother Oncol. 2011 Jul;100(1):15-21. doi: 10.1016/j.radonc.2011.05.024. Epub 2011 May 31.

PMID:
21632132
19.

Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma.

Vandecaveye V, Dirix P, De Keyzer F, Op de Beeck K, Vander Poorten V, Hauben E, Lambrecht M, Nuyts S, Hermans R.

Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1098-107. doi: 10.1016/j.ijrobp.2011.02.044. Epub 2011 Apr 20.

PMID:
21514067
20.

Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results.

Lambrecht M, Vandecaveye V, De Keyzer F, Roels S, Penninckx F, Van Cutsem E, Filip C, Haustermans K.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):863-70. doi: 10.1016/j.ijrobp.2010.12.063. Epub 2011 Mar 11.

PMID:
21398048

Supplemental Content

Loading ...
Support Center